Annual report
4465.TEDINET S100YYMP
Period2025-06-01 → 2026-05-31
Filed2026-08-26
StandardJapan GAAP
ConsolidatedYes
Data checks23 of 24 passed
Amended by S100Z0B0 (2026-09-04).
Key figures · 148
| Metric | Value | Period | Scope | Source row |
|---|---|---|---|---|
| Revenue | ¥24.6bn | 2025-06-01 → 2026-05-31 | Cons. | Net sales |
| Revenue | ¥23.7bn | 2024-06-01 → 2025-05-31 | Cons. | Net sales |
| Revenue | ¥22.7bn | 2023-06-01 → 2024-05-31v | Cons. | Net sales (5-year summary) |
| Revenue | ¥19.5bn | 2022-06-01 → 2023-05-31v | Cons. | Net sales (5-year summary) |
| Revenue | ¥17.8bn | 2021-06-01 → 2022-05-31v | Cons. | Net sales (5-year summary) |
| Operating income | ¥2.1bn | 2025-06-01 → 2026-05-31 | Cons. | Operating income |
| Operating income | ¥1.9bn | 2024-06-01 → 2025-05-31 | Cons. | Operating income |
| Ordinary income | ¥2.2bn | 2025-06-01 → 2026-05-31 | Cons. | Ordinary income |
| Ordinary income | ¥2.0bn | 2024-06-01 → 2025-05-31 | Cons. | Ordinary income |
| Ordinary income | ¥1.5bn | 2023-06-01 → 2024-05-31v | Cons. | Ordinary income loss (5-year summary) |
| Ordinary income | ¥887m | 2022-06-01 → 2023-05-31v | Cons. | Ordinary income loss (5-year summary) |
| Ordinary income | ¥1.9bn | 2021-06-01 → 2022-05-31v | Cons. | Ordinary income loss (5-year summary) |
| Profit before tax | ¥2.7bn | 2025-06-01 → 2026-05-31 | Cons. | Income before income taxes |
| Profit before tax | ¥2.6bn | 2024-06-01 → 2025-05-31 | Cons. | Income before income taxes |
| Net income (owners) | ¥1.9bn | 2025-06-01 → 2026-05-31 | Cons. | Profit loss attributable to owners of parent |
| Net income (owners) | ¥1.8bn | 2024-06-01 → 2025-05-31 | Cons. | Profit loss attributable to owners of parent |
| Net income (owners) | ¥706m | 2023-06-01 → 2024-05-31v | Cons. | Profit loss attributable to owners of parent (5-year summary) |
| Net income (owners) | ¥562m | 2022-06-01 → 2023-05-31v | Cons. | Profit loss attributable to owners of parent (5-year summary) |
| Net income (owners) | ¥1.2bn | 2021-06-01 → 2022-05-31v | Cons. | Profit loss attributable to owners of parent (5-year summary) |
| Net income | ¥1.9bn | 2025-06-01 → 2026-05-31 | Cons. | Profit loss |
| Net income | ¥1.8bn | 2024-06-01 → 2025-05-31 | Cons. | Profit loss |
| Total assets | ¥23.8bn | at 2026-05-31 | Cons. | Assets |
| Total assets | ¥22.6bn | at 2025-05-31 | Cons. | Assets |
| Total assets | ¥22.7bn | at 2024-05-31v | Cons. | Total assets (5-year summary) |
| Total assets | ¥23.6bn | at 2023-05-31v | Cons. | Total assets (5-year summary) |
| Total assets | ¥20.8bn | at 2022-05-31v | Cons. | Total assets (5-year summary) |
| Total liabilities | ¥7.6bn | at 2026-05-31 | Cons. | Liabilities |
| Total liabilities | ¥7.8bn | at 2025-05-31 | Cons. | Liabilities |
| Net assets / equity | ¥16.3bn | at 2026-05-31 | Cons. | Net assets |
| Net assets / equity | ¥14.8bn | at 2025-05-31 | Cons. | Net assets |
| Net assets / equity | ¥13.4bn | at 2024-05-31v | Cons. | Net assets |
| Net assets / equity | ¥13.0bn | at 2023-05-31v | Cons. | Net assets (5-year summary) |
| Net assets / equity | ¥12.5bn | at 2022-05-31v | Cons. | Net assets (5-year summary) |
| Cash and deposits | ¥8.4bn | at 2026-05-31 | Cons. | Cash and deposits |
| Cash and deposits | ¥6.8bn | at 2025-05-31 | Cons. | Cash and deposits |
| Cash & equivalents | ¥7.9bn | at 2026-05-31 | Cons. | Cash and cash equivalents |
| Cash & equivalents | ¥6.5bn | at 2025-05-31 | Cons. | Cash and cash equivalents |
| Cash & equivalents | ¥6.8bn | at 2024-05-31v | Cons. | Cash and cash equivalents |
| Cash & equivalents | ¥6.7bn | at 2023-05-31v | Cons. | Cash and cash equivalents (5-year summary) |
| Cash & equivalents | ¥6.1bn | at 2022-05-31v | Cons. | Cash and cash equivalents (5-year summary) |
| Operating cash flow | ¥2.7bn | 2025-06-01 → 2026-05-31 | Cons. | Net cash provided by used in operating activities |
| Operating cash flow | ¥1.0bn | 2024-06-01 → 2025-05-31 | Cons. | Net cash provided by used in operating activities |
| Operating cash flow | ¥1.3bn | 2023-06-01 → 2024-05-31v | Cons. | Net cash provided by used in operating activities (5-year summary) |
| Operating cash flow | ¥1.1bn | 2022-06-01 → 2023-05-31v | Cons. | Net cash provided by used in operating activities (5-year summary) |
| Operating cash flow | ¥1.6bn | 2021-06-01 → 2022-05-31v | Cons. | Net cash provided by used in operating activities (5-year summary) |
| Investing cash flow | ¥40m | 2025-06-01 → 2026-05-31 | Cons. | Net cash provided by used in investment activities |
| Investing cash flow | −¥420m | 2024-06-01 → 2025-05-31 | Cons. | Net cash provided by used in investment activities |
| Investing cash flow | ¥102m | 2023-06-01 → 2024-05-31v | Cons. | Net cash provided by used in investing activities (5-year summary) |
| Investing cash flow | −¥690m | 2022-06-01 → 2023-05-31v | Cons. | Net cash provided by used in investing activities (5-year summary) |
| Investing cash flow | −¥616m | 2021-06-01 → 2022-05-31v | Cons. | Net cash provided by used in investing activities (5-year summary) |
| Financing cash flow | −¥1.4bn | 2025-06-01 → 2026-05-31 | Cons. | Net cash provided by used in financing activities |
| Financing cash flow | −¥946m | 2024-06-01 → 2025-05-31 | Cons. | Net cash provided by used in financing activities |
| Financing cash flow | −¥1.4bn | 2023-06-01 → 2024-05-31v | Cons. | Net cash provided by used in financing activities (5-year summary) |
| Financing cash flow | −¥92m | 2022-06-01 → 2023-05-31v | Cons. | Net cash provided by used in financing activities (5-year summary) |
| Financing cash flow | −¥789m | 2021-06-01 → 2022-05-31v | Cons. | Net cash provided by used in financing activities (5-year summary) |
| EPS (basic) | ¥321.01 | 2025-06-01 → 2026-05-31 | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥305.84 | 2024-06-01 → 2025-05-31 | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥119.58 | 2023-06-01 → 2024-05-31v | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥95.13 | 2022-06-01 → 2023-05-31v | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥208.59 | 2021-06-01 → 2022-05-31v | Cons. | Basic earnings loss per share (5-year summary) |
| Net assets per share | ¥2,744.08 | at 2026-05-31 | Cons. | Net assets per share (5-year summary) |
| Net assets per share | ¥2,499.68 | at 2025-05-31 | Cons. | Net assets per share (5-year summary) |
| Net assets per share | ¥2,267.35 | at 2024-05-31v | Cons. | Net assets per share (5-year summary) |
| Net assets per share | ¥2,179.33 | at 2023-05-31v | Cons. | Net assets per share (5-year summary) |
| Net assets per share | ¥2,121.49 | at 2022-05-31v | Cons. | Net assets per share (5-year summary) |
| Equity ratio | 68.2% | at 2026-05-31 | Cons. | Equity to asset ratio (5-year summary) |
| Equity ratio | 65.3% | at 2025-05-31 | Cons. | Equity to asset ratio (5-year summary) |
| Equity ratio | 58.9% | at 2024-05-31v | Cons. | Equity to asset ratio (5-year summary) |
| Equity ratio | 54.6% | at 2023-05-31v | Cons. | Equity to asset ratio (5-year summary) |
| Equity ratio | 60.2% | at 2022-05-31v | Cons. | Equity to asset ratio (5-year summary) |
| ROE | 12.3% | 2025-06-01 → 2026-05-31 | Cons. | Rate of return on equity (5-year summary) |
| ROE | 12.8% | 2024-06-01 → 2025-05-31 | Cons. | Rate of return on equity (5-year summary) |
| ROE | 5.4% | 2023-06-01 → 2024-05-31v | Cons. | Rate of return on equity (5-year summary) |
| ROE | 4.4% | 2022-06-01 → 2023-05-31v | Cons. | Rate of return on equity (5-year summary) |
| ROE | 10.3% | 2021-06-01 → 2022-05-31v | Cons. | Rate of return on equity (5-year summary) |
| Employees | 380 | at 2026-05-31 | Cons. | Number of employees |
| Employees | 400 | at 2025-05-31 | Cons. | Number of employees |
| Employees | 394 | at 2024-05-31v | Cons. | Number of employees |
| Employees | 394 | at 2023-05-31v | Cons. | Number of employees |
| Employees | 339 | at 2022-05-31v | Cons. | Number of employees |
| Revenue | ¥21.1bn | 2025-06-01 → 2026-05-31 | Standalone | Net sales |
| Revenue | ¥19.9bn | 2024-06-01 → 2025-05-31 | Standalone | Net sales |
| Revenue | ¥19.1bn | 2023-06-01 → 2024-05-31v | Standalone | Net sales (5-year summary) |
| Revenue | ¥18.4bn | 2022-06-01 → 2023-05-31v | Standalone | Net sales (5-year summary) |
| Revenue | ¥16.9bn | 2021-06-01 → 2022-05-31v | Standalone | Net sales (5-year summary) |
| Operating income | ¥1.8bn | 2025-06-01 → 2026-05-31 | Standalone | Operating income |
| Operating income | ¥1.6bn | 2024-06-01 → 2025-05-31 | Standalone | Operating income |
| Ordinary income | ¥2.0bn | 2025-06-01 → 2026-05-31 | Standalone | Ordinary income |
| Ordinary income | ¥1.7bn | 2024-06-01 → 2025-05-31 | Standalone | Ordinary income |
| Ordinary income | ¥1.2bn | 2023-06-01 → 2024-05-31v | Standalone | Ordinary income loss (5-year summary) |
| Ordinary income | ¥1.0bn | 2022-06-01 → 2023-05-31v | Standalone | Ordinary income loss (5-year summary) |
| Ordinary income | ¥1.8bn | 2021-06-01 → 2022-05-31v | Standalone | Ordinary income loss (5-year summary) |
| Profit before tax | ¥2.4bn | 2025-06-01 → 2026-05-31 | Standalone | Income before income taxes |
| Profit before tax | ¥2.0bn | 2024-06-01 → 2025-05-31 | Standalone | Income before income taxes |
| Net income | ¥1.7bn | 2025-06-01 → 2026-05-31 | Standalone | Profit loss |
| Net income | ¥1.3bn | 2024-06-01 → 2025-05-31 | Standalone | Profit loss |
| Net income | ¥788m | 2023-06-01 → 2024-05-31v | Standalone | Net income loss (5-year summary) |
| Net income | ¥715m | 2022-06-01 → 2023-05-31v | Standalone | Net income loss (5-year summary) |
| Net income | ¥1.2bn | 2021-06-01 → 2022-05-31v | Standalone | Net income loss (5-year summary) |
| Total assets | ¥21.7bn | at 2026-05-31 | Standalone | Assets |
| Total assets | ¥20.5bn | at 2025-05-31 | Standalone | Assets |
| Total assets | ¥20.7bn | at 2024-05-31v | Standalone | Total assets (5-year summary) |
| Total assets | ¥20.6bn | at 2023-05-31v | Standalone | Total assets (5-year summary) |
| Total assets | ¥19.6bn | at 2022-05-31v | Standalone | Total assets (5-year summary) |
| Total liabilities | ¥6.8bn | at 2026-05-31 | Standalone | Liabilities |
| Total liabilities | ¥6.8bn | at 2025-05-31 | Standalone | Liabilities |
| Net assets / equity | ¥14.9bn | at 2026-05-31 | Standalone | Net assets |
| Net assets / equity | ¥13.7bn | at 2025-05-31 | Standalone | Net assets |
| Net assets / equity | ¥12.7bn | at 2024-05-31v | Standalone | Net assets |
| Net assets / equity | ¥12.2bn | at 2023-05-31v | Standalone | Net assets (5-year summary) |
| Net assets / equity | ¥11.7bn | at 2022-05-31v | Standalone | Net assets (5-year summary) |
| Cash and deposits | ¥6.3bn | at 2026-05-31 | Standalone | Cash and deposits |
| Cash and deposits | ¥5.0bn | at 2025-05-31 | Standalone | Cash and deposits |
| EPS (basic) | ¥291.43 | 2025-06-01 → 2026-05-31 | Standalone | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥226.49 | 2024-06-01 → 2025-05-31 | Standalone | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥133.46 | 2023-06-01 → 2024-05-31v | Standalone | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥121.18 | 2022-06-01 → 2023-05-31v | Standalone | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥198.41 | 2021-06-01 → 2022-05-31v | Standalone | Basic earnings loss per share (5-year summary) |
| Dividend per share | ¥77 | 2025-06-01 → 2026-05-31 | Standalone | Dividend paid per share (5-year summary) |
| Dividend per share | ¥92 | 2024-06-01 → 2025-05-31 | Standalone | Dividend paid per share (5-year summary) |
| Dividend per share | ¥44 | 2023-06-01 → 2024-05-31v | Standalone | Dividend paid per share (5-year summary) |
| Dividend per share | ¥64 | 2022-06-01 → 2023-05-31v | Standalone | Dividend paid per share (5-year summary) |
| Dividend per share | ¥28 | 2021-06-01 → 2022-05-31v | Standalone | Dividend paid per share (5-year summary) |
| Net assets per share | ¥2,516.81 | at 2026-05-31 | Standalone | Net assets per share (5-year summary) |
| Net assets per share | ¥2,323.58 | at 2025-05-31 | Standalone | Net assets per share (5-year summary) |
| Net assets per share | ¥2,154.42 | at 2024-05-31v | Standalone | Net assets per share (5-year summary) |
| Net assets per share | ¥2,066.02 | at 2023-05-31v | Standalone | Net assets per share (5-year summary) |
| Net assets per share | ¥1,986.14 | at 2022-05-31v | Standalone | Net assets per share (5-year summary) |
| Equity ratio | 68.8% | at 2026-05-31 | Standalone | Equity to asset ratio (5-year summary) |
| Equity ratio | 66.8% | at 2025-05-31 | Standalone | Equity to asset ratio (5-year summary) |
| Equity ratio | 61.5% | at 2024-05-31v | Standalone | Equity to asset ratio (5-year summary) |
| Equity ratio | 59.2% | at 2023-05-31v | Standalone | Equity to asset ratio (5-year summary) |
| Equity ratio | 60.0% | at 2022-05-31v | Standalone | Equity to asset ratio (5-year summary) |
| ROE | 12.0% | 2025-06-01 → 2026-05-31 | Standalone | Rate of return on equity (5-year summary) |
| ROE | 10.1% | 2024-06-01 → 2025-05-31 | Standalone | Rate of return on equity (5-year summary) |
| ROE | 6.3% | 2023-06-01 → 2024-05-31v | Standalone | Rate of return on equity (5-year summary) |
| ROE | 6.0% | 2022-06-01 → 2023-05-31v | Standalone | Rate of return on equity (5-year summary) |
| ROE | 10.4% | 2021-06-01 → 2022-05-31v | Standalone | Rate of return on equity (5-year summary) |
| Shares issued | 5,943,000 | at 2026-05-31 | Standalone | Total number of issued shares (5-year summary) |
| Shares issued | 5,943,000 | at 2025-05-31 | Standalone | Total number of issued shares (5-year summary) |
| Shares issued | 5,943,000 | at 2024-05-31v | Standalone | Total number of issued shares (5-year summary) |
| Shares issued | 5,943,000 | at 2023-05-31v | Standalone | Total number of issued shares (5-year summary) |
| Shares issued | 5,943,000 | at 2022-05-31v | Standalone | Total number of issued shares (5-year summary) |
| Employees | 242 | at 2026-05-31 | Standalone | Number of employees |
| Employees | 242 | at 2025-05-31 | Standalone | Number of employees |
| Employees | 239 | at 2024-05-31v | Standalone | Number of employees |
| Employees | 239 | at 2023-05-31v | Standalone | Number of employees |
| Employees | 231 | at 2022-05-31v | Standalone | Number of employees |
Periods use the dates stated in the filing. d = earlier-year period dated by calendar; v = that date confirmed by the company's own earlier filing.
Segments · 38
| Segment | Item | Period | Value |
|---|---|---|---|
| Chemical Businessreportable segment | capex | 2025-06-01 → 2026-05-31 | ¥525m |
| Chemical Businessreportable segment | depreciation | 2025-06-01 → 2026-05-31 | ¥496m |
| Chemical Businessreportable segment | employees | at 2026-05-31 | 360 pure |
| Chemical Businessreportable segment | revenue | 2025-06-01 → 2026-05-31 | ¥23.3bn |
| Chemical Businessreportable segment | revenue external | 2025-06-01 → 2026-05-31 | ¥23.3bn |
| Chemical Businessreportable segment | segment assets | at 2026-05-31 | ¥22.0bn |
| Chemical Businessreportable segment | segment profit | 2025-06-01 → 2026-05-31 | ¥1.9bn |
| Healthcare Businessreportable segment | capex | 2025-06-01 → 2026-05-31 | ¥4m |
| Healthcare Businessreportable segment | depreciation | 2025-06-01 → 2026-05-31 | ¥35m |
| Healthcare Businessreportable segment | employees | at 2026-05-31 | 20 pure |
| Healthcare Businessreportable segment | revenue | 2025-06-01 → 2026-05-31 | ¥1.4bn |
| Healthcare Businessreportable segment | revenue external | 2025-06-01 → 2026-05-31 | ¥1.4bn |
| Healthcare Businessreportable segment | segment assets | at 2026-05-31 | ¥1.9bn |
| Healthcare Businessreportable segment | segment profit | 2025-06-01 → 2026-05-31 | ¥212m |
| —segment total | capex | 2025-06-01 → 2026-05-31 | ¥529m |
| —segment total | depreciation | 2025-06-01 → 2026-05-31 | ¥531m |
| —segment total | revenue | 2025-06-01 → 2026-05-31 | ¥24.6bn |
| —segment total | revenue external | 2025-06-01 → 2026-05-31 | ¥24.6bn |
| —segment total | segment assets | at 2026-05-31 | ¥23.8bn |
| —segment total | segment profit | 2025-06-01 → 2026-05-31 | ¥2.1bn |
| Chemical Businessreportable segment | capex | 2024-06-01 → 2025-05-31 | ¥442m |
| Chemical Businessreportable segment | depreciation | 2024-06-01 → 2025-05-31 | ¥497m |
| Chemical Businessreportable segment | revenue | 2024-06-01 → 2025-05-31 | ¥22.2bn |
| Chemical Businessreportable segment | revenue external | 2024-06-01 → 2025-05-31 | ¥22.2bn |
| Chemical Businessreportable segment | segment assets | at 2025-05-31 | ¥20.7bn |
| Chemical Businessreportable segment | segment profit | 2024-06-01 → 2025-05-31 | ¥1.6bn |
| Healthcare Businessreportable segment | capex | 2024-06-01 → 2025-05-31 | ¥9m |
| Healthcare Businessreportable segment | depreciation | 2024-06-01 → 2025-05-31 | ¥36m |
| Healthcare Businessreportable segment | revenue | 2024-06-01 → 2025-05-31 | ¥1.5bn |
| Healthcare Businessreportable segment | revenue external | 2024-06-01 → 2025-05-31 | ¥1.5bn |
| Healthcare Businessreportable segment | segment assets | at 2025-05-31 | ¥1.8bn |
| Healthcare Businessreportable segment | segment profit | 2024-06-01 → 2025-05-31 | ¥278m |
| —segment total | capex | 2024-06-01 → 2025-05-31 | ¥451m |
| —segment total | depreciation | 2024-06-01 → 2025-05-31 | ¥533m |
| —segment total | revenue | 2024-06-01 → 2025-05-31 | ¥23.7bn |
| —segment total | revenue external | 2024-06-01 → 2025-05-31 | ¥23.7bn |
| —segment total | segment assets | at 2025-05-31 | ¥22.6bn |
| —segment total | segment profit | 2024-06-01 → 2025-05-31 | ¥1.9bn |
Segment names come from EDINET member IDs; not yet mapped to a common taxonomy.
All source rows · 1,587
| Item | Context | Value | Unit |
|---|---|---|---|
| Total amount of dividends dividends of surplus | FilingDateInstant_Row2Member | 231208000 | JPY |
| Dividend per share dividends of surplus | FilingDateInstant_Row2Member | 39.0 | |
| Number of male directors and other officers | FilingDateInstant | 6 | |
| Number of female directors and other officers | FilingDateInstant | 2 | |
| Ratio of female directors and other officers | FilingDateInstant | 0.250 | |
| Number of shares held ordinary shares information about directors and corporate auditors | FilingDateInstant_jpcrp030000-asr_E00890-000OkuyamaYoshiakiMember | 68000 | |
| Number of shares held ordinary shares information about directors and corporate auditors | FilingDateInstant_jpcrp030000-asr_E00890-000NojiriDaisukeMember | 16000 | |
| Number of shares held ordinary shares information about directors and corporate auditors | FilingDateInstant_jpcrp030000-asr_E00890-000SakoHaruhikoMember | 7000 | |
| Number of shares held ordinary shares information about directors and corporate auditors | FilingDateInstant_jpcrp030000-asr_E00890-000TakaseKazuhisaMember | 2000 | |
| Number of shares held ordinary shares information about directors and corporate auditors | FilingDateInstant_jpcrp030000-asr_E00890-000OkaKazukiMember | 1000 | |
| Number of shares held ordinary shares information about directors and corporate auditors | FilingDateInstant_jpcrp030000-asr_E00890-000ShimizuHirokoMember | 1000 | |
| Number of shares held ordinary shares information about directors and corporate auditors | FilingDateInstant_jpcrp030000-asr_E00890-000YamamotoAtsumiMember | 0 | |
| Number of shares held ordinary shares information about directors and corporate auditors | FilingDateInstant_jpcrp030000-asr_E00890-000UedaZyunMember | 0 | |
| Number of shares held ordinary shares information about directors and corporate auditors | FilingDateInstant | 98000 | |
| Number of male directors and other officers proposal | FilingDateInstant | 6 | |
| Number of female directors and other officers proposal | FilingDateInstant | 2 | |
| Ratio of female directors and other officers proposal | FilingDateInstant | 0.250 | |
| Number of shares held ordinary shares information about directors and corporate auditors proposal | FilingDateInstant_jpcrp030000-asr_E00890-000OkuyamaYoshiakiMember | 68000 | |
| Number of shares held ordinary shares information about directors and corporate auditors proposal | FilingDateInstant_jpcrp030000-asr_E00890-000NojiriDaisukeMember | 16000 | |
| Number of shares held ordinary shares information about directors and corporate auditors proposal | FilingDateInstant_jpcrp030000-asr_E00890-000SakoHaruhikoMember | 7000 | |
| Number of shares held ordinary shares information about directors and corporate auditors proposal | FilingDateInstant_jpcrp030000-asr_E00890-000TakaseKazuhisaMember | 2000 | |
| Number of shares held ordinary shares information about directors and corporate auditors proposal | FilingDateInstant_jpcrp030000-asr_E00890-000OkaKazukiMember | 1000 | |
| Number of shares held ordinary shares information about directors and corporate auditors proposal | FilingDateInstant_jpcrp030000-asr_E00890-000ShimizuHirokoMember | 1000 | |
| Number of shares held ordinary shares information about directors and corporate auditors proposal | FilingDateInstant_jpcrp030000-asr_E00890-000YamamotoAtsumiMember | 0 | |
| Number of shares held ordinary shares information about directors and corporate auditors proposal | FilingDateInstant_jpcrp030000-asr_E00890-000UedaZyunMember | 0 | |
| Number of shares held ordinary shares information about directors and corporate auditors proposal | FilingDateInstant | 98000 | |
| Audit fees reporting company | Prior1YearDuration | 28000000 | JPY |
| Non audit fees reporting company | Prior1YearDuration | － | JPY |
| Audit fees reporting company | CurrentYearDuration | 28000000 | JPY |
| Non audit fees reporting company | CurrentYearDuration | － | JPY |
| Audit fees consolidated subsidiaries | Prior1YearDuration | － | JPY |
| Non audit fees consolidated subsidiaries | Prior1YearDuration | － | JPY |
| Audit fees consolidated subsidiaries | CurrentYearDuration | － | JPY |
| Non audit fees consolidated subsidiaries | CurrentYearDuration | － | JPY |
| Audit fees total | Prior1YearDuration | 28000000 | JPY |
| Non audit fees total | Prior1YearDuration | － | JPY |
| Audit fees total | CurrentYearDuration | 28000000 | JPY |
| Non audit fees total | CurrentYearDuration | － | JPY |
| Total amount of remuneration etc remuneration etc by category of directors and other officers | CurrentYearDuration_DirectorsExcludingAuditAndSupervisoryCommitteeMembersAndOutsideDirectorsMember | 80276000 | JPY |
| Base remuneration remuneration etc by category of directors and other officers | CurrentYearDuration_DirectorsExcludingAuditAndSupervisoryCommitteeMembersAndOutsideDirectorsMember | 77256000 | JPY |
| Performance based remuneration remuneration by category of directors and other officers | CurrentYearDuration_DirectorsExcludingAuditAndSupervisoryCommitteeMembersAndOutsideDirectorsMember | 3020000 | JPY |
| Retirement benefits remuneration etc by category of directors and other officers | CurrentYearDuration_DirectorsExcludingAuditAndSupervisoryCommitteeMembersAndOutsideDirectorsMember | － | JPY |
| Non monetary remuneration remuneration by category of directors and other officers | CurrentYearDuration_DirectorsExcludingAuditAndSupervisoryCommitteeMembersAndOutsideDirectorsMember | － | JPY |
| Number of directors and other officers remuneration etc by category of directors and other officers | CurrentYearDuration_DirectorsExcludingAuditAndSupervisoryCommitteeMembersAndOutsideDirectorsMember | 4 | |
| Total amount of remuneration etc remuneration etc by category of directors and other officers | CurrentYearDuration_DirectorsAppointedAsAuditAndSupervisoryCommitteeMembersExcludingOutsideDirectorsMember | － | JPY |
| Base remuneration remuneration etc by category of directors and other officers | CurrentYearDuration_DirectorsAppointedAsAuditAndSupervisoryCommitteeMembersExcludingOutsideDirectorsMember | － | JPY |
| Performance based remuneration remuneration by category of directors and other officers | CurrentYearDuration_DirectorsAppointedAsAuditAndSupervisoryCommitteeMembersExcludingOutsideDirectorsMember | － | JPY |
| Retirement benefits remuneration etc by category of directors and other officers | CurrentYearDuration_DirectorsAppointedAsAuditAndSupervisoryCommitteeMembersExcludingOutsideDirectorsMember | － | JPY |
| Non monetary remuneration remuneration by category of directors and other officers | CurrentYearDuration_DirectorsAppointedAsAuditAndSupervisoryCommitteeMembersExcludingOutsideDirectorsMember | － | JPY |
| Number of directors and other officers remuneration etc by category of directors and other officers | CurrentYearDuration_DirectorsAppointedAsAuditAndSupervisoryCommitteeMembersExcludingOutsideDirectorsMember | － |
Every row of the EDINET CSV. Item names are the XBRL element names; filed text is kept in its original Japanese. Filed text is available on Plus and Pro.
Data checks · 23 of 24 passed
| balance sheet identity | pass rounding |
| balance sheet identity | pass rounding |
| balance sheet identity | pass rounding |
| balance sheet identity | pass rounding |
| dei present | pass |
| period resolution | partial |
| statement vs summary · net assets | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net income attributable to parent | pass |
| statement vs summary · net income attributable to parent | pass |
| statement vs summary · operating cash flow | pass |
| statement vs summary · operating cash flow | pass |
| statement vs summary · revenue | pass |
| statement vs summary · revenue | pass |
| statement vs summary · revenue | pass |
| statement vs summary · revenue | pass |
| statement vs summary · total assets | pass |
| statement vs summary · total assets | pass |
| statement vs summary · total assets | pass |
| statement vs summary · total assets | pass |